Clinical trials
Withdrawn Phase 2 Peripheral Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Conjupro Biotherapeutics, Inc. | 1 |
| Georgetown University | 1 |
| National Cancer Institute (NCI) | 1 |
| University of Arizona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Nervous System Diseases | 4 |
| Breast Neoplasms | 2 |
| Heredodegenerative Disorders, Nervous System | 1 |
| Monoclonal Gammopathy of Undetermined Significance | 1 |
| Neoplasms, Nerve Tissue | 1 |
| Neurofibroma, Plexiform | 1 |
| Neurofibromatosis 1 | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.